Krystal Biotech, Inc. (KRYS)
300.88
+0.63
(+0.21%)
USD |
NASDAQ |
Nov 06, 16:00
299.88
-1.00
(-0.33%)
After-Hours: 20:00
Krystal Biotech EPS Diluted (TTM) : 7.364 for Sept. 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 7.364 |
| June 30, 2026 | 7.979 |
| March 31, 2026 | 7.482 |
| December 31, 2025 | 6.844 |
| September 30, 2025 | 6.667 |
| June 30, 2025 | 4.916 |
| March 31, 2025 | 4.152 |
| December 31, 2024 | 2.988 |
| September 30, 2024 | 1.768 |
| June 30, 2024 | 3.654 |
| March 31, 2024 | 1.882 |
| December 31, 2023 | 0.0889 |
| September 30, 2023 | -1.461 |
| June 30, 2023 | -5.421 |
| March 31, 2023 | -5.275 |
| December 31, 2022 | -5.503 |
| September 30, 2022 | -5.205 |
| June 30, 2022 | -4.742 |
| March 31, 2022 | -4.378 |
| December 31, 2021 | -3.133 |
| September 30, 2021 | -2.709 |
| June 30, 2021 | -2.496 |
| Date | Value |
|---|---|
| March 31, 2021 | -2.131 |
| December 31, 2020 | -1.694 |
| September 30, 2020 | -1.476 |
| June 30, 2020 | -1.235 |
| March 31, 2020 | -1.232 |
| December 31, 2019 | -1.209 |
| September 30, 2019 | -1.183 |
| June 30, 2019 | -1.195 |
| March 31, 2019 | -1.047 |
| December 31, 2018 | -0.9718 |
| September 30, 2018 | -0.8245 |
| June 30, 2018 | -1.080 |
| March 31, 2018 | -0.9344 |
| December 31, 2017 | -0.7727 |
| September 30, 2017 | -0.6987 |
| June 30, 2017 | -0.215 |
| March 31, 2017 | -0.1605 |
| December 31, 2016 | -0.1122 |
| September 30, 2016 | -0.051 |
| June 30, 2016 | -0.0196 |
| March 31, 2016 | 0.00 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 19.80 |
| Ionis Pharmaceuticals, Inc. | -3.473 |
| Ultragenyx Pharmaceutical, Inc. | -5.189 |
| BridgeBio Pharma, Inc. | -3.040 |
| Cytokinetics, Inc. | -6.038 |